Ropivacaine Hydrochloride
- Product NDC
- 0409-9302
- 11-digit product format
- 004099302
- Labeler code
- 0409
- Product ID
- 0409-9302_0669f092-f34e-40c2-af54-8004c205032d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ROPIVACAINE HYDROCHLORIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- EPIDURAL; PERINEURAL
- Labeler
- Hospira, Inc.
- Application
- ANDA090194
- Marketing category
- ANDA
- Marketing start
- 2014-09-23
- Marketing end
- 0000-00-00
- Substance
- ROPIVACAINE HYDROCHLORIDE
- Active strength
- 8 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0409-9302-20 | 00409930220 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-9302-20) > 20 mL in 1 VIAL, SINGLE-DOSE (0409-9302-21) | 2014-09-23 | 0000-00-00 | No | No | Current |